ArticleMolecular diversity2022

In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer's disease.

Sairaj Satarker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.